FundedIQ

Funded Consumer Goods Startups in Germany

Among the 13 most recent Germany consumer-goods entries shown, one disclosed round stands far above the rest: Cheplapharm Arzneimittel’s $544M convertible…

Among the 13 most recent Germany consumer-goods entries shown, one disclosed round stands far above the rest: Cheplapharm Arzneimittel’s $544M convertible note on 2022-10-25. The next-largest disclosed amount is zolar’s $109M (2024-04-08), and most other disclosed rounds cluster in the $3M–$8M band, with several small disclosed checks including Interior Circle’s $220K (2023-05-02) and Bedrop’s $100K (2022-02-21).

Geographically, Berlin is the most repeated city, appearing for zolar (2024-04-08), CleanHub (2023-06-21), Cocoli (2021-12-09), her1 (2021-07-21), Lumenaza (2021-06-08), Glambook (2021-05-07), and gitti (2020-09-04). The funding window spans 2020-09-04 to 2026-02-25, with the most recent row being Armira in München (2026-02-25) at an undisclosed amount, and five of 13 rows carrying a “Series Unknown” classification while one additional row is “undisclosed.”

Most recent rounds

13 shown

Related listings

Frequently asked

Which disclosed round is the clear outlier in this Germany consumer-goods list, and what’s the next-largest disclosed check?

Cheplapharm Arzneimittel’s $544M convertible note (2022-10-25) is the dominant outlier; the next-largest disclosed amount is zolar’s $109M (2024-04-08). Most remaining disclosed rounds fall well below $50M, including OYESS Beauty’s $3M (2023-04-03) and Cheplapharm-adjacent small disclosed checks like Interior Circle’s $220K (2023-05-02).

How concentrated are cities, and does Berlin materially dominate the geography?

Berlin appears in 7 of 13 rows: zolar (2024-04-08, $109M), CleanHub (2023-06-21, $7M), Cocoli (2021-12-09, $100K), her1 (2021-07-21, $7M), Lumenaza (2021-06-08, $8M), Glambook (2021-05-07, $600K), and gitti (2020-09-04, $3M). Other cities appear only once each, such as Hamburg for OYESS Beauty (2023-04-03, $3M) and Greifswald for Cheplapharm Arzneimittel (2022-10-25, $544M).

Which entries fall in the most recent 90 days of the listing’s date range?

Using the latest row date shown (2026-02-25 for Armira), only Armira itself is within the prior 90 days window; the next most recent disclosed round in the list is zolar on 2024-04-08. The remainder of dated rounds are earlier than 2025-11-27.

What stage labels show up most often, and how does that compare to known stages?

“Series Unknown” appears in 5 of 13 rows (Armira 2026-02-25 is undisclosed, zolar 2024-04-08 is Series Unknown at $109M, CleanHub 2023-06-21 is Series Unknown at $7M, plus Lumenaza 2021-06-08 and Duschkraft 2021-05-20). Known stage labels are more scattered, with Series A appearing twice (OYESS Beauty $3M on 2023-04-03; her1 $7M on 2021-07-21) and Angel appearing twice (Interior Circle $220K on 2023-05-02; Cocoli $100K on 2021-12-09).

Are there multiple tiny checks that suggest a lower end of disclosed amounts, and what’s the smallest disclosed amount?

The smallest disclosed amount in the rows shown is $100K, held by Bedrop (Seed, 2022-02-21) and also by Cocoli (Angel, 2021-12-09). Below $1M, Interior Circle at $220K (2023-05-02) and Glambook at $600K (2021-05-07) sit well below the higher disclosed outliers like Cheplapharm’s $544M (2022-10-25) and zolar’s $109M (2024-04-08).

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.